 |
|
Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients
Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi, Emmanuel Curis, Virginie Siguret
J Stroke. 2023;25(1):126-131. Published online 2023 Jan 3 DOI: https://doi.org/10.5853/jos.2022.03034
|
|
Citations to this article as recorded by
 Development of a Rapid Qualitative Screen for Anticoagulant Presence
Selena Wong, Jenna Slingerland, Jane A Dickerson, Jennifer Pak, Gavin D Roach, Nabiha H Saifee
The Journal of Applied Laboratory Medicine.2024; 9(2): 305. CrossRef Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
Nicolas Gendron, Paul Billoir, Virginie Siguret, Véronique Le Cam-Duchez, Valérie Proulle, Laurent Macchi, Elodie Boissier, Christine Mouton, Emmanuel De Maistre, Isabelle Gouin-Thibault, Georges Jourdi
Thrombosis Research.2024; 237: 171. CrossRef Challenges to Laboratory Monitoring of Direct Oral Anticoagulants
Jesse Qiao, Minh-Ha Tran
Clinical and Applied Thrombosis/Hemostasis.2024;[Epub] CrossRef DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin
Sophie Melicine, Capucine Habay, Wiame Ghammad, Julie Carré, Jean Luc Diehl, David M. Smadja, Nicolas Gendron, Dominique Helley, Laetitia Mauge
International Journal of Laboratory Hematology.2024; 46(5): 953. CrossRef Brief communication: Heparin‐calibrated chromogenic anti‐Xa assay for the detection of threshold‐levels of direct oral anticoagulants
Delphine De Smet, Dimitri Hemelsoet, Veerle De Herdt, Pieter M. De Kesel, Katrien M. J. Devreese
International Journal of Laboratory Hematology.2024; 46(6): 1136. CrossRef
|